| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/02/2011 | EP2288355A1 Method and composition for skin inflammation and discoloration |
| 03/02/2011 | EP2288349A1 Therapy regimen for treating acne related diseases |
| 03/02/2011 | EP2288345A1 Psycho-pharmaceuticals |
| 03/02/2011 | EP2178511B1 Tableted compositions containing atazanavir |
| 03/02/2011 | EP1686951B1 Combined cosmetic or therapeutic preparation |
| 03/02/2011 | EP1417975B1 Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient |
| 03/02/2011 | EP1248613B1 Clonidine preparations |
| 03/02/2011 | CN1568195B Peptide YY and peptide YY agonists for treatment of metabolic disorders |
| 03/02/2011 | CN101983193A Prophylactic or therapeutic agent for attention deficit/hyperactivity disorder |
| 03/02/2011 | CN101983073A Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation |
| 03/02/2011 | CN101983072A Mineral absorption accelerator and iron deficiency anemia improver or food composition |
| 03/02/2011 | CN101983058A Compositions and methods for alleviating depression or improving cognition |
| 03/02/2011 | CN101983051A Preparation for preventing or ameliorating wrinkles, to be taken orally, through injection, or through external application to skin, and cosmetic method |
| 03/02/2011 | CN101193656B Novel triglyceride reducing agent |
| 03/01/2011 | US7897732 Useful in methods for the induction of bone, cartilage and tissue formation, growth and development of the endometrium and in the acceleration of wound healing |
| 03/01/2011 | US7897635 HIV protease inhibitors |
| 03/01/2011 | US7897628 {2-[3-(4-Methyl-2-[2-methypropoxy]phenyl)-ureido]-thiazol-4-yl}-acetic acid ethyl ester; glucokinase inhibitor; antidiabetic, hypoglycemic agent; activators of glucokinase |
| 03/01/2011 | US7897590 Methods to mobilize progenitor/stem cells |
| 03/01/2011 | US7897351 Peptides and antibodies to MUC 1 proteins |
| 03/01/2011 | US7897180 Enamel matrix protein composition for treatment of systemic inflammatory response |
| 03/01/2011 | US7897175 Cholesteryl ester transfer protein (CETP) such as torcetrapib; 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase); two drugs are separate from each other; improved chemical stability of the HMG-CoA reductase inhibitor |
| 03/01/2011 | US7897165 Covalent binding of a hydrogel to an extracellular matrix; primed extracellular matrix comprises tyrosyl radicals, polymerizable agent is an acrylate; tissue repair, delivery of drugs or cells |
| 03/01/2011 | US7897152 Viral chemokine-antigen fusion proteins |
| 03/01/2011 | US7897145 Methods for the treatment of renal failure |
| 03/01/2011 | CA2688760A1 Transformed human pluripotent stem cells and associated methods |
| 03/01/2011 | CA2601999C Method for ameliorating pruritus |
| 03/01/2011 | CA2469154C Cytotoxic protein and utilization thereof |
| 03/01/2011 | CA2423335C Spray drying process and compositions of fenofibrate |
| 03/01/2011 | CA2368618C Method of enhancing the efficacy of anti-tumor agents |
| 03/01/2011 | CA2348954C A pharmaceutical composition for treating immune diseases |
| 03/01/2011 | CA2323525C Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 02/28/2011 | CA2676946A1 Adam12 inhibitors and their use against inflammation-induced fibrosis |
| 02/24/2011 | WO2011021594A1 Sustained drug delivery system |
| 02/24/2011 | WO2011020853A1 Compositions containing mixtures of fermentable fibers |
| 02/24/2011 | US20110046546 Methods for treating headaches |
| 02/24/2011 | US20110046190 Combinations comprising a selective cyclooxygenase-2 inhibitor |
| 02/24/2011 | US20110046150 Use of n--4-(3-pyridyl)-2-pyridine-amine for the treatment of pulmonary hypertension |
| 02/24/2011 | US20110045589 Methods Of Controlling Proliferation And Differentiation Of Stem And Progenitor Cells |
| 02/24/2011 | US20110045583 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof |
| 02/24/2011 | US20110045107 Dietary Supplement and Method for the Treatment of Digestive Tract Ulcers in Equines |
| 02/24/2011 | US20110045032 Composition, formulations & kit for treatment of respiratory and lung disease with dehydroepiandrosterone(s) steroid & an anti-muscarinic agent(s) |
| 02/24/2011 | US20110044947 Methods of treating cardiac disorders |
| 02/24/2011 | US20110044912 Diagnostic And Therapeutic Epitope, And Transgenic Plant |
| 02/24/2011 | DE20321830U1 Mittelkettige Triglyeride (MCT) zur ernährungsphysiologischen Optimierung des Fettsäurenspektrums in einem diätischen Lebensmittel für Diabetiker Medium Triglyeride (MCT) to optimize the nutritional fatty acids spectrum in a dietetic foods for diabetics |
| 02/24/2011 | DE202010015929U1 Medikamenten aufweisendes medizinisches Produkt zur Anwendung an den Blutgefäßen Drugs exhibiting a medical device for application to the blood vessels |
| 02/24/2011 | DE10251709C5 Screening-Verfahren für Wirkstoffe zur Stimulierung der humanen beta-Defensine vom Typ 2 und/oder Typ 3 Screening method for agents to stimulate the human beta-defensins type 2 and / or type 3 |
| 02/23/2011 | EP2287608A2 Biomarkers for cardiovascular side-effects induced by cox-2 inhibitory compounds |
| 02/23/2011 | EP2287285A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 02/23/2011 | EP2287204A1 Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes |
| 02/23/2011 | EP2287191A2 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
| 02/23/2011 | EP2287190A2 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
| 02/23/2011 | EP2287186A1 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
| 02/23/2011 | EP2287183A1 Mutants PF4 polypeptides exhibiting an increased anti-angiogenic activity |
| 02/23/2011 | EP2287182A2 Differential in tumour gene products and use of same |
| 02/23/2011 | EP2287181A2 Differential in tumour gene products and use of same |
| 02/23/2011 | EP2286876A1 Parasiticidal composition |
| 02/23/2011 | EP2286840A2 Treatment of obesity and related diseases |
| 02/23/2011 | EP2286839A2 Treatment of obesity and related diseases |
| 02/23/2011 | EP2286838A2 Treatment of obesity and related disorders |
| 02/23/2011 | EP2286837A2 Treatment of obesity and obesity related diseases |
| 02/23/2011 | EP2286836A1 Immunostimulating agent |
| 02/23/2011 | EP2286827A1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 02/23/2011 | EP2286826A2 Treatment of tumor metastase and cancer |
| 02/23/2011 | EP2286820A1 Buffered Compositions for dialysis |
| 02/23/2011 | EP2286817A2 Method of treating functional bowel disorders |
| 02/23/2011 | EP2286804A1 A method of treating degenerative disc disease |
| 02/23/2011 | EP2286799A2 Microspheres for active embolization |
| 02/23/2011 | EP2286798A1 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 02/23/2011 | EP2286666A1 Versatile disinfectant |
| 02/23/2011 | EP2285419A1 Hepatoprotectant acetaminophen mutual prodrugs |
| 02/23/2011 | EP2285410A2 Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation |
| 02/23/2011 | EP2285406A2 Inhibitory effects of nordihydroguaiaretic acid (ndga) on the igf-1 receptor and androgen dependent growth of lapc-4 prostate cancer cells |
| 02/23/2011 | EP2285398A2 Methods and compositions for the treatment of obesity |
| 02/23/2011 | EP2285384A2 Boron-containing small molecules |
| 02/23/2011 | EP2285371A2 Pharmaceutical formulations and methods of use which combine non-steroidal anti-inflammatory compounds with anti-hypertensive compounds |
| 02/23/2011 | EP2285369A2 Sulfobetaines for cancer, obesity, macular degeneration, neurodegenerative diseases |
| 02/23/2011 | EP2285218A2 Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging |
| 02/23/2011 | EP2285216A1 Hiv protease inhibitor and cytochrome p450 inhibitor combinations |
| 02/23/2011 | EP1962843B1 Use of parp-1 inhibitors |
| 02/23/2011 | EP1634589B1 Aqueous olanexidine solution, method of preparing the same, and disinfectant |
| 02/23/2011 | EP1505989B1 Manipulation of the rate of gastrointestinal transit by modulating intestinal methane concentration |
| 02/23/2011 | CN1934252B Thrombin derivatives and medicinal composition containing the same |
| 02/23/2011 | CN101981047A Novel lupane derivatives |
| 02/23/2011 | CN101980708A 5imidazoquinolines and pyrimidine derivatives as potent modulators of VEGF-driven angiogenic processes |
| 02/23/2011 | CN101980705A Use of benzophenone derivative or salt thereof and TNF alpha inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor |
| 02/23/2011 | CN101980017A Anti-TNF antibodies, compositions, methods and uses |
| 02/23/2011 | CN101979412A IL-18 binding proteins |
| 02/23/2011 | CN101979095A Treatment and diagnosis of macrophage mediated disease |
| 02/23/2011 | CN101979090A Medicament for treating tumors |
| 02/22/2011 | US7893297 Amorphous sodium 4-[4-chloro-2-hydroxybenzoyl)amino]butanoate |
| 02/22/2011 | US7893285 Transdermal compositions |
| 02/22/2011 | US7893252 Selectively depolymerized galactomannan polysaccharide |
| 02/22/2011 | US7893237 Haemophilus influenzae type IV pili |
| 02/22/2011 | US7893217 Isolated human antibodies that bind epitopes on RG1 |
| 02/22/2011 | US7893209 Slo2, novel potassium channel proteins from human brain |
| 02/22/2011 | US7893087 3(R)-1-Phenethyl-(9[H]-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2] octane quaternary salt with a mono- or polyvalent anion; antimuscarinic agents used to treat chronic obstructive pulmonary disease, chronic bronchitis, bronchial hyperreactivity, asthma, or rhinitis |
| 02/22/2011 | US7893084 Viral polymerase inhibitors |
| 02/22/2011 | US7893054 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 02/22/2011 | US7892818 Method and kit for the determination of cellular activation profiles |
| 02/22/2011 | US7892782 Screening process for antibacterial agents |